{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T22:50:27Z","timestamp":1788648627745,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangxi Natural Science Foundation","award":["2020GXNSFAA259030"],"award-info":[{"award-number":["2020GXNSFAA259030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Lei-gong-gen formula granule (LFG) is a folk prescription derived from Zhuang nationality, the largest ethnic minority among 56 nationalities in China. It consists of three herbs, namely<jats:italic>Eclipta prostrata<\/jats:italic>(L.) L.,<jats:italic>Smilax glabra<\/jats:italic>Roxb, and<jats:italic>Centella asiatica<\/jats:italic>(L.) Urb. It has been widely used as health protection tea for hundreds of years to prevent hypertension in Guangxi Zhuang Autonomous Region. The purpose of this study is to validate the antihypertensive effect of LFG on the spontaneously hypertensive rat (SHR) model, and to further identify the effective components and anti-hypertension mechanism of LFG.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The effects of LFG on blood pressure, body weight, and heart rate were investigated<jats:italic>in vivo<\/jats:italic>using the SHR model. The levels of NO, ANG II, and ET-1 in the serum were measured, and pathological changes in the heart were examined by H&amp;E staining. The main active components of LFG, their corresponding targets, and hypertension associated pathways were discerned through network pharmacology analysis based on the Traditional Chinese Medicine Systems Pharmacology (TCMSP), Traditional Chinese Medicine Integrated Database (TCMID), and the Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM). Then the predicted results were further verified by molecular biology experiments such as RT-qPCR and western blot. Additionally, the potential active compounds were predicted by molecular docking technology, and the chemical constituents of LFG were analyzed and identified by UPLC-QTOF\/MS technology. Finally, an<jats:italic>in vitro<\/jats:italic>assay was performed to investigate the protective effects of potential active compounds against hydrogen peroxide (H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>) induced oxidative damage in human umbilical vein endothelial cells (HUVEC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>LFG could effectively reduce blood pressure and increase serum NO content in SHR model. Histological results showed that LFG could ameliorate pathological changes such as cardiac hypertrophy and interstitial inflammation. From network pharmacology analysis, 53 candidate active compounds of LFG were collected, which linked to 765 potential targets, and 828 hypertension associated targets were retrieved, from which 12 overlapped targets both related to candidate active compounds from LFG and hypertension were screened and used as the potential targets of LFG on antihypertensive effect. The molecular biology experiments of the 12 overlapped targets showed that LFG could upregulate the mRNA and protein expressions of NOS3 and proto-oncogene tyrosine-protein kinase SRC (SRC) in the thoracic aorta. Pathway enrichment analysis showed that the PI3K-AKT signaling pathway was closely related to the expression of NOS3 and SRC. Moreover, western blot results showed that LFG significantly increased the protein expression levels of PI3K and phosphorylated AKT in SHR model, suggesting that LFG may active the PI3K-AKT signaling pathway to decrease hypertension. Molecular docking study further supported that p-hydroxybenzoic acid, cedar acid, shikimic acid, salicylic acid, nicotinic acid, linalool, and histidine can be well binding with NOS3, SRC, PI3K, and AKT. UPLC-QTOF\/MS analysis confirmed that p-hydroxybenzoic acid, shikimic acid, salicylic acid, and nicotinic acid existed in LFG. Pre-treatment of HUVEC with nicotinic acid could alleviate the effect on cell viability induced by H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>and increase the NO level in cell supernatants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>LFG can reduce the blood pressure in SHR model, which might be attributed to increasing the NO level in serum for promoting vasodilation via upregulating SRC expression level and activating the PI3K-AKT-NOS3 signaling pathway. Nicotinic acid might be the potential compound for LFG antihypertensive effect.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13020-021-00507-1","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T18:25:32Z","timestamp":1633890332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["A network pharmacology-based approach to explore the active ingredients and molecular mechanism of Lei-gong-gen formula granule on a spontaneously hypertensive rat model"],"prefix":"10.1186","volume":"16","author":[{"given":"Qiaofeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taijin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4046-2643","authenticated-orcid":false,"given":"Hongwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"507_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ctim.2017.02.005","volume":"31","author":"H Wang","year":"2017","unstructured":"Wang H, Liu C, Zhai J, Shang H. Niuhuang Jiangya Preparation (a traditional Chinese patent medicine) for essential hypertension: a systematic review. Complement Ther Med. 2017;31:90\u20139.","journal-title":"Complement Ther Med"},{"key":"507_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ijcard.2016.10.110","volume":"227","author":"Y Li","year":"2017","unstructured":"Li Y, Yang L, Wang L, Zhang M, Huang Z, Deng Q, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol. 2017;227:516\u201323.","journal-title":"Int J Cardiol"},{"issue":"18","key":"507_CR3","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","volume":"289","author":"K Wolf-Maier","year":"2003","unstructured":"Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363\u20139.","journal-title":"JAMA"},{"issue":"3","key":"507_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ctim.2015.04.008","volume":"23","author":"X Xiong","year":"2015","unstructured":"Xiong X, Wang P, Li X, Zhang Y. Shenqi pill, a traditional Chinese herbal formula, for the treatment of hypertension: a systematic review. Complement Ther Med. 2015;23(3):484\u201393.","journal-title":"Complement Ther Med"},{"key":"507_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fphar.2020.00345","volume":"11","author":"W Wu","year":"2020","unstructured":"Wu W, Yang S, Liu P, Yin L, Gong Q, Zhu W. Systems pharmacology-based strategy to investigate pharmacological mechanisms of radix puerariae for treatment of hypertension. Front Pharmacol. 2020;11:345.","journal-title":"Front Pharmacol"},{"issue":"19","key":"507_CR6","first-page":"3718","volume":"40","author":"XT Ye","year":"2015","unstructured":"Ye XT, Zhang BX, Wang HH, He SB, Zhang XH, Wang Y. Study on mechanism for anti-hypertension efficacy of Eucommiae Cortex through assistant analysis systems for acting mechanisms of traditional Chinese medicine. China J Chin Materia Medica. 2015;40(19):3718\u201322.","journal-title":"China J Chin Materia Medica"},{"key":"507_CR7","first-page":"2171","volume":"9","author":"TJ Lan","year":"2018","unstructured":"Lan TJ, Liang WP, Feng QY, Yun CX, Guo HW. Multi-index integrated evaluation method optimizes water-extraction of Leigong Antihypertensive Granules. J Chin Med Mater. 2018;9:2171\u20134.","journal-title":"J Chin Med Mater."},{"issue":"8","key":"507_CR8","first-page":"963","volume":"33","author":"RB Xin","year":"2011","unstructured":"Xin RB, Meng GY, He L, Lu J, Huang WY, Ye LL, et al. Sampling survey of hypertension in Zhuang nationality in Tiandong county. Guangxi Med J. 2011;33(8):963\u20135.","journal-title":"Guangxi Med J"},{"issue":"16","key":"507_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1055\/a-1008-6138","volume":"85","author":"NNM Razali","year":"2019","unstructured":"Razali NNM, Ng CT, Fong LY. Cardiovascular protective effects of centella asiatica and its triterpenes: a review. Planta Med. 2019;85(16):1203\u201315.","journal-title":"Planta Med"},{"issue":"Suppl 2","key":"507_CR10","first-page":"195-S8","volume":"31","author":"FEF Astutik","year":"2021","unstructured":"Astutik FEF, Fauzia Zuhroh D, Rizqi Lazuardi Ramadhan M. The effect of gotu kola (Centella asiatica L.) tea on blood pressure of hypertension. Enferm Clin. 2021;31(Suppl 2):195-S8.","journal-title":"Enferm Clin"},{"issue":"11","key":"507_CR11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/1440-1681.12472","volume":"42","author":"S Bunbupha","year":"2015","unstructured":"Bunbupha S, Prachaney P, Kukongviriyapan U, Kukongviriyapan V, Welbat JU, Pakdeechote P. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension. Clin Exp Pharmacol Physiol. 2015;42(11):1189\u201397.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"9","key":"507_CR12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/tox.22577","volume":"33","author":"MY Liao","year":"2018","unstructured":"Liao MY, Chuang CY, Hsieh MJ, Chou YE, Lin CW, Chen WR, et al. Antimetastatic effects of Eclipta prostrata extract on oral cancer cells. Environ Toxicol. 2018;33(9):923\u201330.","journal-title":"Environ Toxicol"},{"issue":"13","key":"507_CR13","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1007\/s00253-017-8363-9","volume":"101","author":"IM Chung","year":"2017","unstructured":"Chung IM, Rajakumar G, Lee JH, Kim SH, Thiruvengadam M. Ethnopharmacological uses, phytochemistry, biological activities, and biotechnological applications of Eclipta prostrata. Appl Microbiol Biotechnol. 2017;101(13):5247\u201357.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"507_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2007.08.012","volume":"171","author":"F Sa","year":"2008","unstructured":"Sa F, Gao JL, Fung KP, Zheng Y, Lee SM, Wang YT. Anti-proliferative and pro-apoptotic effect of Smilax glabra Roxb. extract on hepatoma cell lines. Chem Biol Interact. 2008;171(1):1\u201314.","journal-title":"Chem Biol Interact"},{"key":"507_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jep.2015.04.026","volume":"169","author":"Y Cai","year":"2015","unstructured":"Cai Y, Tu J, Pan S, Jiang J, Shou Q, Ling Y, et al. Medicinal effect and its JP2\/RyR2-based mechanism of Smilax glabra flavonoids on angiotensin II-induced hypertrophy model of cardiomyocytes. J Ethnopharmacol. 2015;169:435\u201340.","journal-title":"J Ethnopharmacol"},{"issue":"19","key":"507_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S1359-6446(04)03213-1","volume":"9","author":"CG Wermuth","year":"2004","unstructured":"Wermuth CG. Multitargeted drugs: the end of the \u201cone-target-one-disease\u201d. philosophy? Drug Discov Today. 2004;9(19):826\u20137.","journal-title":"philosophy? Drug Discov Today"},{"issue":"2","key":"507_CR17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","volume":"11","author":"S Li","year":"2013","unstructured":"Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11(2):110\u201320.","journal-title":"Chin J Nat Med"},{"key":"507_CR18","doi-asserted-by":"crossref","first-page":"495840","DOI":"10.1155\/2014\/495840","volume":"2014","author":"H Li","year":"2014","unstructured":"Li H, Zhao L, Zhang B, Jiang Y, Wang X, Guo Y, et al. A network pharmacology approach to determine active compounds and action mechanisms of ge-gen-qin-lian decoction for treatment of type 2 diabetes. Evid Based Complement Alternat Med. 2014;2014:495840.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"507_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/wjtcm.wjtcm_11_21","volume":"7","author":"S Li","year":"2021","unstructured":"Li S, Chen Y, Ding Q, Dai J, Duan X, Hu Y, et al. Network pharmacology evaluation method guidance \u2013 Draft. World J Tradit Chin Med. 2021;7(1):146\u201354.","journal-title":"World J Tradit Chin Med"},{"issue":"1","key":"507_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","volume":"145","author":"W Tao","year":"2013","unstructured":"Tao W, Xu X, Wang X, Li B, Wang Y, Li Y, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol. 2013;145(1):1\u201310.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"507_CR21","first-page":"1356","volume":"42","author":"T Lan","year":"2019","unstructured":"Lan T, Chang M, Li Q, Liang W, Yun C, Guo H. Optimization of formation process for leigong antihypertensive granules by central composite design-respones surface methodology based on CRITIC Weighted Evaluation. J Chin Med Mater. 2019;42(6):1356\u20139.","journal-title":"J Chin Med Mater"},{"key":"507_CR22","doi-asserted-by":"publisher","first-page":"112989","DOI":"10.1016\/j.jep.2020.112989","volume":"260","author":"T Lan","year":"2020","unstructured":"Lan T, Li Q, Chang M, Yin C, Zhu D, Wu Z, et al. Lei-gong-gen formula granule attenuates hyperlipidemia in rats via cGMP-PKG signaling pathway. J Ethnopharmacol. 2020;260:112989.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"507_CR23","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3109\/10641968009037162","volume":"2","author":"JF Giudicelli","year":"1980","unstructured":"Giudicelli JF, Freslon JL, Glasson S, Richer C. Captopril and hypertension development in the SHR. Clin Exp Hypertens. 1980;2(6):1083\u201396.","journal-title":"Clin Exp Hypertens"},{"key":"507_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.","journal-title":"J Cheminform"},{"issue":"Database issue","key":"507_CR25","first-page":"D1089-95","volume":"41","author":"R Xue","year":"2013","unstructured":"Xue R, Fang Z, Zhang M, Yi Z, Wen C, Shi T. TCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Res. 2013;41(Database issue):D1089-95.","journal-title":"Nucleic Acids Res"},{"key":"507_CR26","doi-asserted-by":"publisher","first-page":"21146","DOI":"10.1038\/srep21146","volume":"6","author":"Z Liu","year":"2016","unstructured":"Liu Z, Guo F, Wang Y, Li C, Zhang X, Li H, et al. BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine. Sci Rep. 2016;6:21146.","journal-title":"Sci Rep"},{"issue":"6","key":"507_CR27","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.3390\/ijms13066964","volume":"13","author":"X Xu","year":"2012","unstructured":"Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, et al. A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012;13(6):6964\u201382.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"507_CR28","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1093\/bioinformatics\/btt270","volume":"29","author":"J Gong","year":"2013","unstructured":"Gong J, Cai C, Liu X, Ku X, Jiang H, Gao D, et al. ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method. Bioinformatics. 2013;29(14):1827\u20139.","journal-title":"Bioinformatics"},{"key":"507_CR29","doi-asserted-by":"publisher","first-page":"bas061","DOI":"10.1093\/database\/bas061","volume":"2013","author":"HJ Dai","year":"2013","unstructured":"Dai HJ, Wu JC, Tsai RT, Pan WH, Hsu WL. T-HOD: a literature-based candidate gene database for hypertension, obesity and diabetes. Database. 2013;2013:bas061.","journal-title":"Database"},{"issue":"11","key":"507_CR30","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"D1","key":"507_CR31","doi-asserted-by":"publisher","first-page":"D607-D13","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607-D13.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"507_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"4","key":"507_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"8","key":"507_CR34","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41440-019-0248-0","volume":"42","author":"M Arif","year":"2019","unstructured":"Arif M, Sadayappan S, Becker RC, Martin LJ, Urbina EM. Epigenetic modification: a regulatory mechanism in essential hypertension. Hypertens Res. 2019;42(8):1099\u2013113.","journal-title":"Hypertens Res"},{"issue":"7","key":"507_CR35","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1097\/HJH.0b013e3283472643","volume":"29","author":"H Makani","year":"2011","unstructured":"Makani H, Bangalore S, Romero J, Htyte N, Berrios RS, Makwana H, et al. Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate\u2013a meta-analysis of randomized trials. J Hypertens. 2011;29(7):1270\u201380.","journal-title":"J Hypertens"},{"issue":"3","key":"507_CR36","doi-asserted-by":"publisher","first-page":"e156-66","DOI":"10.1111\/j.1755-5922.2010.00258.x","volume":"30","author":"MA Raebel","year":"2012","unstructured":"Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther. 2012;30(3):e156-66.","journal-title":"Cardiovasc Ther"},{"issue":"7","key":"507_CR37","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/hr.2013.18","volume":"36","author":"X Xiong","year":"2013","unstructured":"Xiong X, Yang X, Liu Y, Zhang Y, Wang P, Wang J. Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science. Hypertens Res. 2013;36(7):570\u20139.","journal-title":"Hypertens Res"},{"issue":"7","key":"507_CR38","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cellsig.2011.02.008","volume":"23","author":"S Banquet","year":"2011","unstructured":"Banquet S, Delannoy E, Agouni A, Dessy C, Lacomme S, Hubert F, et al. Role of G(i\/o)-Src kinase-PI3K\/Akt pathway and caveolin-1 in beta(2)-adrenoceptor coupling to endothelial NO synthase in mouse pulmonary artery. Cell Signal. 2011;23(7):1136\u201343.","journal-title":"Cell Signal"},{"issue":"3","key":"507_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijcard.2006.10.006","volume":"120","author":"DI Shah","year":"2007","unstructured":"Shah DI, Singh M. Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction. Int J Cardiol. 2007;120(3):317\u201324.","journal-title":"Int J Cardiol"},{"issue":"2","key":"507_CR40","first-page":"114","volume":"1602","author":"MC Frame","year":"2002","unstructured":"Frame MC. Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta. 2002;1602(2):114\u201330.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"507_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jash.2012.01.002","volume":"6","author":"TM Paravicini","year":"2012","unstructured":"Paravicini TM, Montezano AC, Yusuf H, Touyz RM. Activation of vascular p38MAPK by mechanical stretch is independent of c-Src and NADPH oxidase: influence of hypertension and angiotensin II. J Am Soc Hypertens. 2012;6(3):169\u201378.","journal-title":"J Am Soc Hypertens"},{"issue":"35","key":"507_CR42","doi-asserted-by":"publisher","first-page":"25130","DOI":"10.1074\/jbc.274.35.25130","volume":"274","author":"H He","year":"1999","unstructured":"He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1\/KDR activation of c-Src. J Biol Chem. 1999;274(35):25130\u20135.","journal-title":"J Biol Chem"},{"issue":"8","key":"507_CR43","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/10739680490517749","volume":"11","author":"JW Gu","year":"2004","unstructured":"Gu JW, Fortepiani LA, Reckelhoff JF, Adair TH, Wang J, Hall JE. Increased expression of vascular endothelial growth factor and capillary density in hearts of spontaneously hypertensive rats. Microcirculation. 2004;11(8):689\u201397.","journal-title":"Microcirculation"},{"issue":"3","key":"507_CR44","doi-asserted-by":"publisher","first-page":"R944-50","DOI":"10.1152\/ajpregu.2001.281.3.R944","volume":"281","author":"AM Dorrance","year":"2001","unstructured":"Dorrance AM, Osborn HL, Grekin R, Webb RC. Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats. Am J Physiol Regul Integr Comp Physiol. 2001;281(3):R944-50.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"18","key":"507_CR45","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1016\/S0021-9258(18)43497-7","volume":"255","author":"H Ushiro","year":"1980","unstructured":"Ushiro H, Cohen S. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem. 1980;255(18):8363\u20135.","journal-title":"J Biol Chem"},{"issue":"5","key":"507_CR46","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2174\/138955709788167619","volume":"9","author":"J Beltowski","year":"2009","unstructured":"Beltowski J, Lowicka E. EGF receptor as a drug target in arterial hypertension. Mini Rev Med Chem. 2009;9(5):526\u201338.","journal-title":"Mini Rev Med Chem"},{"issue":"2","key":"507_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/HJH.0b013e32834f043b","volume":"30","author":"A Martin","year":"2012","unstructured":"Martin A, Perez-Giron JV, Hernanz R, Palacios R, Briones AM, Fortuno A, et al. Peroxisome proliferator-activated receptor-gamma activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress. J Hypertens. 2012;30(2):315\u201326.","journal-title":"J Hypertens"},{"issue":"1","key":"507_CR48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1006\/excr.1998.4204","volume":"244","author":"DB Clemow","year":"1998","unstructured":"Clemow DB, Spitsbergen JM, McCarty R, Steers WD, Tuttle JB. Arterial nerve growth factor (NGF) mRNA, protein, and vascular smooth muscle cell NGF secretion in hypertensive and hyperactive rats. Exp Cell Res. 1998;244(1):196\u2013205.","journal-title":"Exp Cell Res"},{"key":"507_CR49","doi-asserted-by":"publisher","first-page":"42965","DOI":"10.1038\/srep42965","volume":"7","author":"X Xiong","year":"2017","unstructured":"Xiong X, Yang X, Duan L, Liu W, Zhang Y, Liu Y, et al. Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats. Sci Rep. 2017;7:42965.","journal-title":"Sci Rep"},{"issue":"1","key":"507_CR50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jnutbio.2009.11.004","volume":"22","author":"Y Mukai","year":"2011","unstructured":"Mukai Y, Sato S. Polyphenol-containing azuki bean (Vigna angularis) seed coats attenuate vascular oxidative stress and inflammation in spontaneously hypertensive rats. J Nutr Biochem. 2011;22(1):16\u201321.","journal-title":"J Nutr Biochem"},{"issue":"15","key":"507_CR51","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.lfs.2007.08.008","volume":"81","author":"T Kumai","year":"2007","unstructured":"Kumai T, Takeba Y, Matsumoto N, Nakaya S, Tsuzuki Y, Yanagida Y, et al. Fasudil attenuates sympathetic nervous activity in the adrenal medulla of spontaneously hypertensive rats. Life Sci. 2007;81(15):1193\u20138.","journal-title":"Life Sci"},{"issue":"16","key":"507_CR52","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1111\/bph.12751","volume":"171","author":"S Crnkovic","year":"2014","unstructured":"Crnkovic S, Egemnazarov B, Jain P, Seay U, Gattinger N, Marsh LM, et al. NPY\/Y(1) receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension. Br J Pharmacol. 2014;171(16):3895\u2013907.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"507_CR53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/00004872-199504000-00003","volume":"13","author":"MC Michel","year":"1995","unstructured":"Michel MC, Rascher W. Neuropeptide Y: a possible role in hypertension? J Hypertens. 1995;13(4):385\u201395.","journal-title":"J Hypertens"},{"issue":"4","key":"507_CR54","doi-asserted-by":"publisher","first-page":"H1235-48","DOI":"10.1152\/ajpheart.00254.2009","volume":"298","author":"R Rajkumar","year":"2010","unstructured":"Rajkumar R, Konishi K, Richards TJ, Ishizawar DC, Wiechert AC, Kaminski N, et al. Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension. Am J Physiol Heart Circ Physiol. 2010;298(4):H1235-48.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"507_CR55","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/HYPERTENSIONAHA.111.00728","volume":"61","author":"W Xing","year":"2013","unstructured":"Xing W, Yan W, Liu P, Ji L, Li Y, Sun L, et al. A novel mechanism for vascular insulin resistance in normotensive young SHRs: hypoadiponectinemia and resultant APPL1 downregulation. Hypertension. 2013;61(5):1028\u201335.","journal-title":"Hypertension"},{"issue":"3","key":"507_CR56","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/01.ATV.0000254855.24394.f9","volume":"27","author":"E Yamamoto","year":"2007","unstructured":"Yamamoto E, Yamashita T, Tanaka T, Kataoka K, Tokutomi Y, Lai ZF, et al. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects. Arterioscler Thromb Vasc Biol. 2007;27(3):556\u201363.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"507_CR57","doi-asserted-by":"publisher","first-page":"H2383-94","DOI":"10.1152\/ajpheart.00178.2011","volume":"301","author":"S Nemoto","year":"2011","unstructured":"Nemoto S, Kobayashi T, Taguchi K, Matsumoto T, Kamata K. Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2\/Src\/Akt pathway in type 2 diabetic Goto-Kakizaki rats. Am J Physiol Heart Circ Physiol. 2011;301(6):H2383-94.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"507_CR58","first-page":"2","volume":"1","author":"KP Chong","year":"2009","unstructured":"Chong KP, Rossall S, Atong M. In vitro antimicrobial activity and fungitoxicity of syringic acid, caffeic acid and 4-hydroxybenzoic acid against ganoderma boninense. J Agric Sci. 2009;1:2.","journal-title":"J Agric Sci."},{"key":"507_CR59","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.foodres.2018.01.026","volume":"106","author":"M Figueiredo-Gonzalez","year":"2018","unstructured":"Figueiredo-Gonzalez M, Reboredo-Rodriguez P, Gonzalez-Barreiro C, Simal-Gandara J, Valentao P, Carrasco-Pancorbo A, et al. Evaluation of the neuroprotective and antidiabetic potential of phenol-rich extracts from virgin olive oils by in vitro assays. Food Res Int. 2018;106:558\u201367.","journal-title":"Food Res Int."},{"key":"507_CR60","unstructured":"Ling WC, Ahmad F, Mat Ali R. Luteolin and 4-Hydroxybenzoic Acid from the Leaves Vitex negundo. 2005."},{"key":"507_CR61","first-page":"2","volume":"22","author":"J Chaudhary","year":"2013","unstructured":"Chaudhary J, Jain A, Manuja R, Sachdeva S. A comprehensive review on biological activities of p-hydroxy benzoic acid and its derivatives. Int J Pharm Sci Rev Res. 2013;22:2.","journal-title":"Int J Pharm Sci Rev Res."},{"issue":"1\u20133","key":"507_CR62","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejphar.2010.09.038","volume":"649","author":"Y Leeya","year":"2010","unstructured":"Leeya Y, Mulvany MJ, Queiroz EF, Marston A, Hostettmann K, Jansakul C. Hypotensive activity of an n-butanol extract and their purified compounds from leaves of Phyllanthus acidus (L.) Skeels in rats. Eur J Pharmacol. 2010;649(1\u20133):301\u201313.","journal-title":"Eur J Pharmacol"},{"key":"507_CR63","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.biopha.2018.09.069","volume":"108","author":"C Srinivasulu","year":"2018","unstructured":"Srinivasulu C, Ramgopal M, Ramanjaneyulu G, Anuradha CM, Suresh Kumar C. Syringic acid (SA) A Review of Its Occurrence, Biosynthesis, Pharmacological and Industrial Importance. Biomed Pharmacother. 2018;108:547\u201357.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"507_CR64","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/01.fjc.0000211746.78454.50","volume":"47","author":"T Jalili","year":"2006","unstructured":"Jalili T, Carlstrom J, Kim S, Freeman D, Jin H, Wu TC, et al. Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. J Cardiovasc Pharmacol. 2006;47(4):531\u201341.","journal-title":"J Cardiovasc Pharmacol"},{"key":"507_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.15373\/2249555X\/FEB2014\/17","volume":"4","author":"M Kiran p, Denn.i","year":"2011","unstructured":"Kiran p, Denn.i M, Daniel M. Antidiabetic Principles, Phospholipids And Fixed Oil of Kodo Millet (Paspalum scrobiculatum Linn.). Indian Journal of Applied Research. 2011;4:13\u20135.","journal-title":"Indian Journal of Applied Research"},{"issue":"12","key":"507_CR66","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00210-012-0802-7","volume":"385","author":"S Kumar","year":"2012","unstructured":"Kumar S, Prahalathan P, Raja B. Syringic acid ameliorates (L)-NAME-induced hypertension by reducing oxidative stress. Naunyn Schmiedebergs Arch Pharmacol. 2012;385(12):1175\u201384.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"507_CR67","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4161\/bioe.24435","volume":"4","author":"Y Benmalek","year":"2013","unstructured":"Benmalek Y, Yahia OA, Belkebir A, Fardeau ML. Anti-microbial and anti-oxidant activities of Illicium verum, Crataegus oxyacantha ssp monogyna and Allium cepa red and white varieties. Bioengineered. 2013;4(4):244\u20138.","journal-title":"Bioengineered"},{"issue":"10","key":"507_CR68","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1248\/cpb.44.1908","volume":"44","author":"T Nakamura","year":"1996","unstructured":"Nakamura T, Okuyama E, Yamazaki M. Neurotropic components from star anise (Illicium verum Hook. fil.). Chem Pharm Bull (Tokyo). 1996;44(10):1908\u201314.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"507_CR69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1472-6882-9-27","volume":"9","author":"TS Thring","year":"2009","unstructured":"Thring TS, Hili P, Naughton DP. Anti-collagenase, anti-elastase and anti-oxidant activities of extracts from 21 plants. BMC Complement Altern Med. 2009;9:27.","journal-title":"BMC Complement Altern Med"},{"key":"507_CR70","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.intimp.2016.07.016","volume":"39","author":"TK Rabelo","year":"2016","unstructured":"Rabelo TK, Guimaraes AG, Oliveira MA, Gasparotto J, Serafini MR, de Souza Araujo AA, et al. Shikimic acid inhibits LPS-induced cellular pro-inflammatory cytokines and attenuates mechanical hyperalgesia in mice. Int Immunopharmacol. 2016;39:97\u2013105.","journal-title":"Int Immunopharmacol"},{"key":"507_CR71","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/CCID.S84765","volume":"8","author":"T Arif","year":"2015","unstructured":"Arif T. Salicylic acid as a peeling agent: a comprehensive review. Clin Cosmet Investig Dermatol. 2015;8:455\u201361.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"507_CR72","first-page":"695","volume":"17","author":"J Han","year":"2009","unstructured":"Han J, He GS, Liu JW, Peter A, Chen PP. Anti-oxidant Effects of Xinjiang Red Raspberry Fruit Extracts in Spontaneously Hypertensive Rats. Chinese Journal of Hypertension. 2009;17(8):695\u20139.","journal-title":"Chinese Journal of Hypertension"},{"issue":"6","key":"507_CR73","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/00041433-200412000-00006","volume":"15","author":"CD Meyers","year":"2004","unstructured":"Meyers CD, Kamanna VS, Kashyap ML. Niacin therapy in atherosclerosis. Curr Opin Lipidol. 2004;15(6):659\u201365.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"507_CR74","doi-asserted-by":"publisher","first-page":"F106-13","DOI":"10.1152\/ajprenal.00126.2009","volume":"297","author":"KH Cho","year":"2009","unstructured":"Cho KH, Kim HJ, Rodriguez-Iturbe B, Vaziri ND. Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am J Physiol Renal Physiol. 2009;297(1):F106-13.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"507_CR75","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbagen.2009.10.009","volume":"1800","author":"KH Cho","year":"2010","unstructured":"Cho KH, Kim HJ, Kamanna VS, Vaziri ND. Niacin improves renal lipid metabolism and slows progression in chronic kidney disease. Biochim Biophys Acta. 2010;1800(1):6\u201315.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"507_CR76","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.phymed.2008.08.001","volume":"16","author":"VM Linck","year":"2009","unstructured":"Linck VM, da Silva AL, Figueiro M, Piato AL, Herrmann AP, Dupont Birck F, et al. Inhaled linalool-induced sedation in mice. Phytomedicine. 2009;16(4):303\u20137.","journal-title":"Phytomedicine"},{"key":"507_CR77","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.colsurfb.2018.08.001","volume":"171","author":"I Pereira","year":"2018","unstructured":"Pereira I, Severino P, Santos AC, Silva AM, Souto EB. Linalool bioactive properties and potential applicability in drug delivery systems. Colloids Surf B Biointerfaces. 2018;171:566\u201378.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"507_CR78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bcp.2018.02.014","volume":"151","author":"SB Camargo","year":"2018","unstructured":"Camargo SB, Simoes LO, Medeiros CFA, de Melo Jesus A, Fregoneze JB, Evangelista A, et al. Antihypertensive potential of linalool and linalool complexed with beta-cyclodextrin: Effects of subchronic treatment on blood pressure and vascular reactivity. Biochem Pharmacol. 2018;151:38\u201346.","journal-title":"Biochem Pharmacol"},{"key":"507_CR79","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/ph11040111","volume":"11","author":"M Vera-Aviles","year":"2018","unstructured":"Vera-Aviles M, Vantana E, Kardinasari E, Koh NL, Latunde-Dada GO. Protective Role of Histidine Supplementation Against Oxidative Stress Damage in the Management of Anemia of Chronic Kidney Disease. Pharmaceuticals (Basel). 2018;11:4.","journal-title":"Pharmaceuticals (Basel)."},{"issue":"6","key":"507_CR80","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1053\/j.ajkd.2011.12.026","volume":"59","author":"KR Tuttle","year":"2012","unstructured":"Tuttle KR, Milton JE, Packard DP, Shuler LA, Short RA. Dietary amino acids and blood pressure: a cohort study of patients with cardiovascular disease. Am J Kidney Dis. 2012;59(6):803\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"507_CR81","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1440-1681.2009.05227.x","volume":"37","author":"H Toba","year":"2010","unstructured":"Toba H, Nakamori A, Tanaka Y, Yukiya R, Tatsuoka K, Narutaki M, et al. Oral L-histidine exerts antihypertensive effects via central histamine H3 receptors and decreases nitric oxide content in the rostral ventrolateral medulla in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2010;37(1):62\u20138.","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-021-00507-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-021-00507-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-021-00507-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T17:38:22Z","timestamp":1725903502000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-021-00507-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1186\/s13020-021-00507-1","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"17 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental procedures were approved by the Institutional Animal Ethics Committee (IAEC), Guangxi Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}